BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,187,955 | -46.3% | 2,098,250 | -35.2% | 0.20% | -46.0% |
| Q2 2023 | $147,448,106 | -38.9% | 3,236,350 | -45.6% | 0.38% | -39.6% |
| Q1 2023 | $241,407,036 | +9.5% | 5,951,850 | +37.6% | 0.62% | +1.1% |
| Q4 2022 | $220,524,254 | +42.6% | 4,326,550 | +50.7% | 0.62% | +37.5% |
| Q3 2022 | $154,624,000 | -6.8% | 2,870,850 | +11.1% | 0.45% | -4.9% |
| Q2 2022 | $165,961,000 | -2.2% | 2,583,850 | +18.1% | 0.47% | +4.4% |
| Q1 2022 | $169,654,000 | -33.3% | 2,187,950 | -26.1% | 0.45% | -29.2% |
| Q4 2021 | $254,219,000 | -17.2% | 2,961,550 | -22.4% | 0.64% | -20.0% |
| Q3 2021 | $307,002,000 | +50.6% | 3,817,014 | +50.8% | 0.80% | +48.0% |
| Q2 2021 | $203,811,000 | -21.9% | 2,531,814 | -18.1% | 0.54% | -25.0% |
| Q1 2021 | $260,873,000 | +5.4% | 3,093,114 | +0.3% | 0.72% | +8.5% |
| Q4 2020 | $247,509,000 | +22.1% | 3,084,614 | +22.4% | 0.66% | +14.2% |
| Q3 2020 | $202,643,000 | -6.3% | 2,519,814 | +0.3% | 0.58% | -8.8% |
| Q2 2020 | $216,296,000 | +161.2% | 2,512,149 | +146.3% | 0.64% | +100.3% |
| Q1 2020 | $82,818,000 | +71.0% | 1,020,049 | +76.1% | 0.32% | +183.0% |
| Q4 2019 | $48,444,000 | -67.0% | 579,330 | -65.5% | 0.11% | -68.9% |
| Q3 2019 | $146,917,000 | +43.9% | 1,679,630 | +34.7% | 0.36% | +41.7% |
| Q2 2019 | $102,099,000 | +49.3% | 1,246,630 | +48.2% | 0.25% | +47.7% |
| Q1 2019 | $68,379,000 | +33.1% | 840,963 | +7.8% | 0.17% | +22.9% |
| Q4 2018 | $51,364,000 | -75.3% | 780,366 | -71.1% | 0.14% | -72.4% |
| Q3 2018 | $208,186,000 | -11.3% | 2,700,558 | -15.0% | 0.51% | -19.5% |
| Q2 2018 | $234,638,000 | +9.6% | 3,177,658 | -3.4% | 0.63% | +8.8% |
| Q1 2018 | $214,057,000 | -10.4% | 3,291,158 | -11.0% | 0.58% | -9.9% |
| Q4 2017 | $238,907,000 | +10.0% | 3,695,958 | +6.8% | 0.64% | +4.7% |
| Q3 2017 | $217,112,000 | +6.4% | 3,459,958 | +2.7% | 0.62% | -8.6% |
| Q2 2017 | $204,041,000 | +15.4% | 3,370,344 | -1.2% | 0.67% | +16.0% |
| Q1 2017 | $176,834,000 | +18.3% | 3,409,840 | +1.1% | 0.58% | +1.4% |
| Q4 2016 | $149,494,000 | -0.7% | 3,371,548 | +6.6% | 0.57% | -10.8% |
| Q3 2016 | $150,600,000 | -30.4% | 3,163,873 | -33.9% | 0.64% | -41.7% |
| Q2 2016 | $216,415,000 | +254.9% | 4,785,814 | +222.4% | 1.10% | +222.3% |
| Q1 2016 | $60,985,000 | +14.8% | 1,484,534 | +6.7% | 0.34% | +7.9% |
| Q4 2015 | $53,101,000 | +162.7% | 1,391,906 | +126.2% | 0.32% | +148.8% |
| Q3 2015 | $20,214,000 | -11.8% | 615,334 | +87.7% | 0.13% | -27.8% |
| Q2 2015 | $22,924,000 | +5.4% | 327,810 | +3.2% | 0.18% | +5.4% |
| Q1 2015 | $21,751,000 | +9786.8% | 317,534 | +10484.5% | 0.17% | +8250.0% |
| Q4 2014 | $220,000 | -97.9% | 3,000 | -98.0% | 0.00% | -97.6% |
| Q3 2014 | $10,528,000 | +12.9% | 146,682 | +13.7% | 0.08% | +13.7% |
| Q2 2014 | $9,328,000 | +101.2% | 129,022 | +104.8% | 0.07% | +73.8% |
| Q1 2014 | $4,636,000 | +6.9% | 63,000 | +1.1% | 0.04% | 0.0% |
| Q4 2013 | $4,336,000 | -56.2% | 62,342 | -58.6% | 0.04% | -64.4% |
| Q3 2013 | $9,902,000 | -19.0% | 150,742 | -14.6% | 0.12% | -32.6% |
| Q2 2013 | $12,218,000 | – | 176,412 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |